Last edition
News about "immunology research"
Meiji Seika Pharma Initiates Phase I Trial of ME3241 PD-1 Agonist Antibody for Autoimmune Diseases
Meiji Seika Pharma Co., Ltd. has launched a Phase I clinical trial of ME3241, a novel anti-PD-1 agonist antibody developed with Foundation for Biomedical Research and Innovation at Kobe for autoimmune disease treatment.
Immunology Research | 16/03/2026 | By News Bureau
Mabtech and Sai Life Sciences Partner to Advance Immunology Research
Under this collaboration, Mabtech and Sai will jointly deliver advanced immunology assay services — including high-sensitivity multiplex cytokine and phenotyping workflows — powered by the EYRA platform installed at Sai’s Boston discovery site.
Immunology Research | 31/01/2026 | By News Bureau
Matchpoint, Novartis Partner to Develop Oral Inhibitors for Multiple Inflammatory Diseases
Matchpoint Therapeutics has entered into an exclusive option and license agreement with Novartis to develop and commercialise oral covalent inhibitors for multiple inflammatory diseases.
Immunology Research | 28/07/2025 | By Dineshwori | 162
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy